Whatman™ FAST Quant Human Angiogenesis by GE Healthcare
Manufacturer GE Healthcare
FAST Quant™ represents a quantum leap forward in protein microarray technology. With FAST Quant, a researcher can accurately determine the concentration of several cytokines in dozens of biological samples simultaneously, using familiar ELISA immunochemistry.
Built on FAST technology, the high protein binding capacity surface chemistry, FAST Quant combines the power of array technology with the quantitative nature and high-throughput capabilities of traditional ELISA. FAST Quant exhibits greate... Read more
Whatman™ FAST Quant Human Angiogenesis
FAST Quant™ represents a quantum leap forward in protein microarray technology. With FAST Quant, a researcher can accurately determine the concentration of several cytokines in dozens of biological samples simultaneously, using familiar ELISA immunochemistry.
Built on FAST technology, the high protein binding capacity surface chemistry, FAST Quant combines the power of array technology with the quantitative nature and high-throughput capabilities of traditional ELISA. FAST Quant exhibits greater sensitivity and reproducibility than traditional ELISA.
Whatman™ FAST Quant Human Angiogenesis detects the following cytokines:
- PDGF-BB
- KGF
- VEGF
- TIMP-1
- FGFβ
- ICAM-1
- Angiogenin
- Angiopoietin-2
Product Overview
